Complementary and Alternative Medicine (CAM):

Migraine Headaches

This page is focused on CAM treatment of headaches, an approach that emphasizes  reducing the frequency and severity of headaches. 

For conventional management of headaches, see: Accurate Education – headaches.

 

Complementary and Alternative Medicine (CAM) is defined by the National Institutes of Health (NIH) Center for Complementary and Alternative Medicine as, “those treatments and healthcare practices not taught widely in medical schools, not generally used in hospitals, and not usually reimbursed by medical insurance companies.”
See Complementary and Alternative Medicine (CAM)

 

See also:

Headaches – Low Volume CSF Headaches

For information regarding individual foods, nutrients, vitamins and supplements:

   Nutrition and Pain.

CAM – Migraine Headaches

 Chronic headaches are a common problem, affecting an estimated 28 million Americans. There are many types of headaches although migraine and tension headaches account for the vast majority. For those who suffer from chronic daily headaches, defined as more than 15 debilitating headaches per month, the distinction between migraine and tension headache can become blurred as these headaches begin to blend in character and behavior.  

The management of chronic headaches is an extensive subject and includes emergency management, abortive management of acute headaches and preventative management. At this time, the focus here will be on preventative management with emphasis on CAM supplements. It should be stressed, however, that behavioral approaches to headache prevention are extremely important and effective means of reducing the frequency and severity of debilitating headaches. Behavioral approaches include exercise, cognitive behavior therapy, deep relaxation techniques, yoga, tai chi, and mindful exercises such as meditation.

See: CBT, Yoga and Tai Chi).

While pharmaceutical interventions remain the cornerstone of migraine management, nutraceuticals and dietary interventions offer evidence-based, complementary therapeutic strategies with favorable safety profiles and multifactorial mechanisms of action. This comprehensive treatise synthesizes current evidence on nutraceuticals, dietary patterns, and nutritional interventions for migraine prevention and treatment, organized by level of evidence and clinical applicability.

The therapeutic rationale for nutraceuticals in migraine encompasses multiple pathophysiological mechanisms that contribute to vulnerabilty of triggering a migraine:

  • Mitochondrial energy metabolism optimization
  • Oxidative stress reduction
  • Neuroinflammation suppression
  • Gut-brain axis modulation,
  • Neurotransmitter regulation.

Nutraceuticals modulate these conditions and cellular functions via pathways similar to pharmaceuticals but generally demonstrate superior tolerability profiles, making them particularly valuable for pediatric populations, patients with medication intolerance, and those seeking integrative approaches.[1][2][3]

IMPORTANT:

  • While many nutraceuticals — particularly CoQ10, riboflavin, and magnesium— and certain herbs can be very effective as single nutraceutical therapy (monotherapy), combining different nutraceuticals together often works better by working on different mechanisms simultaneously for prevention of migraines.
  • Many nutraceuticals not only work with different mechanisms of action, but their benefits often work effectively for symptoms of other conditions as well. For example, CoQ10 is an important and potent agent for combatting mitochondrial dysfunction, which is a significant contributor to many conditions, including fibromyalgia, fatigue and neuropathy.
  • Nutraceuticals often require at least 3 months to achieve benefit and they work best in combination with others

Part I: Evidence-Based Nutraceutical Interventions

Individual Nutraceuticals

see below for synergistic combinations

Level A Evidence (Established Efficacy)

Riboflavin (Vitamin B2)

  • What it does: Riboflavin helps your brain cells produce energy more efficiently, which may prevent migraine attacks from starting.
  • The evidence: Studies show that about 6 out of 10 people who take riboflavin experience at least a 50% reduction in migraine severity and It typically reduces frequency of migraines by 1-2 per month.
  • Dose: 400 mg once daily
  • When to expect results: 4-12 weeks (be patient!)
  • Duration: Continue taking it as long as it’s helping
  • Side effects: Very safe. Your urine will turn bright yellow-orange, which is completely harmless
  • Mechanism: Riboflavin serves as precursor to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), essential cofactors for mitochondrial electron transport chain complexes I and II. Supplementation enhances mitochondrial oxygen consumption and ATP production, addressing the energy deficit hypothesis of migraine.[2][3][7][6]

Clinical Evidence: 

– Adult Prophylaxis: 400 mg/day for 3 months demonstrates significant efficacy in multiple RCTs. Meta-analysis shows 50% responder rate of 59% versus 15% for placebo (NNT: 2.3). Reduces attack frequency (MD = -1.34), duration, and severity.[2][3][7]

– Pediatric Use: Low-dose riboflavin (10-40 mg/day) for 3 months shows modest efficacy in children without comorbid headaches, with significant reduction in migraine frequency. However, evidence quality is lower than adult studies.[25][7]

– Combination Therapy: Synergistic effects observed when combined with other mitochondrial nutrients (CoQ10, magnesium).[6]

Safety Profile:

Excellent tolerability with minimal adverse events. Harmless yellow-orange urine discoloration occurs universally. No serious adverse events reported in clinical trials.[2][7]

Clinical Recommendations: Riboflavin 400 mg/day represents a first-line nutraceutical option for adult migraine prophylaxis based on strong evidence, excellent safety, low cost, and ease of use. Particularly appropriate for patients preferring non-pharmaceutical approaches, those with medication intolerance, and as adjunctive therapy.[2][3][7]

 

Coenzyme Q10 (Ubiquinone)

This enzyme cofactor may be effective in reducing the frequency of migraine headaches by up to 50%, CoQ10 has few side effects (gastrointestinal, incidence less than 1%). It is considered safe for older children. and is also likely effective in fibromyalgia.

  • What it does: CoQ10 is an antioxidant that helps cells produce energy and                          protect brain cells from damage.
  • The evidence: About half of people taking CoQ10 experience at least a 50% reduction in migraines. It reduces frequency, duration, and severity of attacks.
  • Dose: 100-400 mg daily (most studies use 300 mg)
  • Best absorption: Take with a meal containing some fat
  • When to expect results: 4-12 weeks
  • Side effects: Very safe with minimal side effects, occasionally mild stomach upset.
  • Mechanism: CoQ10 functions as electron carrier in mitochondrial respiratory chain and potent lipophilic antioxidant. Reduces oxidative stress, enhances ATP synthesis, stabilizes mitochondrial membranes, and decreases pro-inflammatory cytokines (TNF-α) and CGRP levels.[2][3][7][26][6]

Clinical Evidence:

– Adult Prophylaxis: 100-400 mg/day for 3 months significantly reduces frequency, duration, and severity. Meta-analysis demonstrates 50% responder rate of 47.6% versus 14.4% for placebo (NNT: 3).[2][3]

– Pediatric Efficacy: Comparable therapeutic benefit to amitriptyline in children with superior tolerability and fewer adverse events. Represents important option given limited pediatric migraine therapeutics.[26]

– Combination Therapy: Synergistic effects with nano-curcumin demonstrated in RCT (n=100), with combination superior to either agent alone for frequency, severity, duration, and quality of life measures.[27]

– Bioavailability: Enhanced with fat-containing meals; ubiquinol form may offer superior absorption

Safety Profile: Excellent safety with low adverse event rates. Mild gastrointestinal symptoms occasionally reported. No serious adverse events in clinical trials.[2][3][7][26]

Clinical Recommendations: CoQ10 300 mg/day represents Level C evidence for migraine prophylaxis with favorable risk-benefit ratio. Particularly valuable in pediatric populations as alternative to tricyclic antidepressants, and in combination approaches targeting mitochondrial dysfunction.[2][3][7][26]

See: CoQ10

 

Magnesium

  • What it does: Magnesium helps regulate nerve signals, blood vessel function, and brain chemicals involved in migraines. Many people with migraines have low magnesium levels.
  • The evidence: Magnesium reduces migraine severity and frequency by about 2-3 attacks/month.
  • Dose: 500-600 mg daily
  • Best forms: Mg citrate or Mg glycinate are better absorbed and tolerated than Mg oxide
  • When to expect results: 4-12 weeks
  • Side effects: Diarrhea or stomach upset, especially at higher doses. Start with a low dose and gradually increase. Avoid if you have kidney problems.
  • Mechanism: Magnesium regulates over 300 enzymatic reactions including mitochondrial ATP synthesis. Modulates NMDA receptors preventing excitotoxicity, regulates voltage-gated calcium channels, inhibits platelet aggregation and serotonin release, prevents cortical spreading depression, and reduces substance P and glutamate release.[2][3][7][21][22]

Clinical Evidence:

Oral Prophylaxis: Meta-analysis demonstrates mean reduction of 2.6 migraine headaches per month after 12 weeks of supplementation. Reduces attack frequency (MD = -2.51), severity (MD = -0.88), and monthly migraine days (MD = -1.66).[7][3]

Intravenous Acute Treatment: 1-2 grams IV magnesium sulfate relieves acute migraine attacks within 15 minutes to 24 hours, particularly effective for migraine with aura and menstrual migraine.[2][7]

Deficiency Prevalence: Serum magnesium levels significantly lower during ictal and interictal phases in migraine patients compared to controls. Pediatric migraineurs also demonstrate lower levels.[21][22]

Combination Therapy: Enhances antimigraine properties of sodium valproate, allowing dose reduction and potentially reducing valproate-related adverse effects.[7]

Safety Profile: Generally well-tolerated. Primary adverse effect is dose-dependent diarrhea and gastrointestinal discomfort, limiting tolerability in some patients. Contraindicated in renal insufficiency. IV administration requires monitoring for hypotension and respiratory depression.[2][7]

Clinical Recommendations: Magnesium supplementation recommended for migraine prophylaxis with Level B evidence. Particularly appropriate for patients with documented deficiency, menstrual migraine, and as adjunctive therapy. IV magnesium represents effective acute treatment option, especially for migraine with aura.[2][3][7][21][22]

Omega-3 Fatty Acids (EPA and DHA)

  • What they do: Reduce inflammation in the brain and nervous system.
  • The evidence: Significantly reduce migraine frequency and severity, especially in women.
  • Dose: 1,800 to 2,400 mg EPA + DHA daily (check the label for EPA + DHA content, not just “fish oil”)
  • Duration: 12 weeks minimum
  • Side effects: Occasional mild stomach upset. Take with meals to minimize this.
  • Dietary approach: Eating fatty fish (salmon, mackerel, sardines) 2-3 x/week & reducing vegetable oils helps.

Level B Evidence (Probable Efficacy)

Vitamin D

  • What it does: Vitamin D reduces inflammation and helps regulate brain chemicals. Many migraine sufferers are deficient in vitamin D.
  • The evidence: Studies show vitamin D supplementation reduces migraine frequency by about 2-3 attacks per month and decreases severity.
  • Dose: 1,000 to 4,000 IU/day, but preferentially based on blood levels
  • Mechanism: Vitamin D functions as neurosteroid with pleiotropic effects: anti-inflammatory (reduces IL-6, iNOS, Cox-2), antioxidant, neuroprotective, modulates neurotrophic factors, regulates calcium homeostasis, and influences serotonergic and dopaminergic neurotransmission.[18][19][20][28][29]

Clinical Evidence:

Deficiency Prevalence: 45-100% of migraine patients demonstrate vitamin D deficiency or insufficiency, with inverse correlation between serum levels and headache frequency.[18][19]

Supplementation Efficacy: Meta-analyses demonstrate vitamin D supplementation significantly reduces:

  • – Headache attacks per month [20]
  • – Headache days per month [20]

Supplements With Moderate Evidence – Recommended

Alpha-Lipoic Acid

  • Dose: 300-600 mg daily
  • Evidence: Reduces migraine frequency and severity

Curcumin (Turmeric)

  • Dose: Nano-curcumin formulations work best (600 mg twice daily)
  • Evidence: Works especially well when combined with omega-3s or CoQ10

Ginger

  • Dose: 250-500 mg at the start of a migraine
  • Evidence: May help reduce acute migraine pain, similar to some medications

Combination Synergies for Enhanced Effectiveness

Common Combinations for Enhanced Effectiveness

These combinations target multiple mechanisms simultaneously and work better than single supplements:

  • Co10 + L-Carnitine (500 mg/day) (a mitochondrial energy duo)
  • Riboflavin + Magnesium + CoQ10 (a mitochondrial energy trio)
  • Omega-3 + Curcumin (anti-inflammatory combination)
  • CoQ10 + Curcumin (mitochondrial energy + anti-inflammatory)

See the handout: “Synergy Combinations of Nutraceuticals for Migraine for more enhancement combinations

Combination for Enhanced Synergistic Effectiveness

While many nutraceuticals and certain herbs can be very effective as single agents (monotherapy), combining different nutraceuticals together can often work better because they combine multiple mechanisms of action simultaneously directed at reducing susceptibility to migraine triggers.

Several combination nutraceutical formulations demonstrate synergistic benefits for migraine prevention, with the most robust evidence supporting combinations of magnesium, CoQ10, riboflavin (vitamin B2), and the herb, feverfew. Studies on the following fixed-dose combinations demonstrate responder rates of 50-65% and may offer advantages over monotherapy through complementary mechanisms that target key drivers of migraine headaches:

  • Mitochondrial dysfunction
  • Oidative stress
  • Neuroinflammation
  • Neurotransmitter activity

IMPORTANT: Nutraceuticals may require at least 3 months to achieve benefit

Specific Combination Formulations with Good Evidence

1. Magnesium + CoQ10 + Feverfew (3-Component Formulation)

The most extensively studied combination includes magnesium 112.5 mg, CoQ10 100 mg, and feverfew 100 mg. A 2019 review identified this triple combination as beneficial for migraine prevention. The rationale combines magnesium’s NMDA receptor antagonism and neuromuscular effects, CoQ10’s mitochondrial energy support, and feverfew’s anti-inflammatory properties.

2. Magnesium + Vitamin B2 + Feverfew + Andrographis Paniculata + CoQ10

This combination targets multiple pathophysiological mechanisms simultaneously:

Mitochondrial dysfunction (CoQ10, vitamin B2), oxidative stress (CoQ10, andrographis paniculata), neuroinflammation (feverfew, andrographis paniculata),and neuromuscular excitability (magnesium). A three months study of this 5-Component Formulation in 113 patients with episodic migraine evaluating this combination of five components demonstrated:

    • Significant reduction in monthly migraine days: a 35% reduction
    • 56.6% responder rate (≥50% reduction in monthly migraine days)
    • Reduced days with peak headache intensity >4/10 (5.7 vs. 4.9 )
    • Decreased break-thru medication use: 8.9 vs. 5.7 ± 3.4 days/month
    • Significant improvements in disability and quality of life
    • No safety concerns: Well-tolerated with no reported side effects

Comparison to Monotherapy

The 56.6% responder rate achieved with thie above five-component formulation compares favorably to monotherapy data noted below:

  • CoQ10 monotherapy: 47.6% responder rate (NNT=3)
  • Riboflavin monotherapy: >50% responder rate (NNT=2.3)
  • Magnesium monotherapy: Reduces attacks by 2.51 per month

NNT = Number of people needed to treat to have one success

Only two randomized, placebo-controlled trials have directly compared combination nutraceuticals to single-agent therapy for migraine prevention, both demonstrating superior effectiveness for the combinations:

  1. 1Curcumin (80 mg nano-formulation) + CoQ10 (300 mg) showed the strongest evidence for synergy
  2. CoQ10 (80 mg) + L-Carnitine (500 mg): Both improve mitochondrial function with different mechanisms

Evidence for Synergy

Omega-3 Fatty Acids + Nano-Curcumin:

Both have anti-inflammatory properties with distinct mechanisms. Studies of Omega-3 (2500 mg) + nano-curcumin (80 mg) showed reduced frequency of migraines with superior anti-inflammatory effects (reduced TNF-α, IL-6 and hs-CRP.) compared to either agent alone.

The Mechanistic Rational for Combination Therapy

The theoretical advantage of combining nutraceuticals with noted migraine benefits derives from targeting their multiple physiological mechanisms involved with migraine prevention simultaneously. Note that some nutraceuticals offer multiple mechanisms.

Mitochondrial energy metabolism: Good mitochondrial function is necessary to provide adequate energy for cells to function properly. The “energy deficit hypothesis” of migraine suggests that impaired mitochondrial function creates vulnerability to migraine triggers. Combining multiple mitochondrial cofactors may provide more comprehensive metabolic support than monotherapy.

The following nutraceuticals help prevent migraine due by enhancing mitochondrial function:

  • CoQ10,
  • Riboflavin
  • L-Carnitine
  • Magnesium

Oxidative stress and antioxidant defense: Impaired mitochondrial function contributes to increased oxidative damage to cells, referred to as “oxidative stress.” Oxidative damage in nerves triggers neuroinflammation, another contributing factor for migraines.

The following nutraceuticals help prevent migraine due to their anti-inflammatory and/or antioxidant benefits:

  • CoQ10
  • Omega-3
  • Curcumin
  • Vitamin D
  • Ginger
  • Feverfew
  • Andrographis paniculata (Green Chiretta)

Modifying Neurotransmitter activity: Nutraceuticals that may stabilize nerve excitability may help prevent migraines by affecting synthesis of neural transformers or activity of nerve transmission.

The following nutraceuticals help prevent migraine by suppressing neurotransmitter activity:

  • Riboflavin influences neurotransmitter synthesis
  • 5HT (5-hydroxytryptophan) serves as a serotonin precursor.
  • Magnesium acts as an NMDA receptor antagonist and modulates calcium channels.

Dietary Approaches

The therapeutic doses of these nutrients for migraine prevention (100-600 mg daily) generally requires the use of supplements, as food sources usually cannot achieve these levels.

See: Diet and Superfoods rich in migraine-beneficial nutrients

  • Drink 8-10 glasses of water through the day. Dehydration is a common migraine trigger.
  • Consider limiting common migraine trigger foods: Alcohol (especially red wine) excessive Caffeine, Processed meats that contain nitrates, Aged cheeses (contain tyramine), Artificial Sweeteners (especially aspartame), MSG (monosodium glutamate)

Fiber & Probiotics:

Probiotics & dietary fiber 25-38 gms/day (25gm – women, 38gm – men), reduce migraines frequency

  • Mechanism: Modulate gut-brain axis through nervous, endocrine, and immune pathways. Reduce intestinal permeability, decrease pro-inflammatory cytokine release, and may lower cortisol levels. Enhance production of SCFAs, GABA, and serotonin.[1][5][6]
  • Evidence:[2][3][5]
  1. Multispecies probiotic supplementation (14 strains) for 8-10 weeks significantly reduces attack frequency, severity, duration, and medication consumption in episodic and chronic migraine
  2. Synbiotic supplementation (12 probiotic strains + fructooligosaccharides) for 12 weeks reduces attack frequency, medication use, digestive problems, zonulin, and hs-CRP levels
  3. Meta-analysis shows reduction in frequency (MD = -1.16), severity (MD = -1.07), and monthly migraine days (MD = -3.02)
  4. Strain-specific and dose-dependent effects

Gut Microbiome in Migraine: Altered gut microbiota composition documented in both episodic and chronic migraine patients. Higher PAC000195_g composition associated with lower headache frequency; Agathobacter negatively associated with severe headache intensity.*[12]

Recommendation: Multispecies probiotic formulations for 8-12 weeks. Purity, strain type, and dosage are important considerations. Further trials needed to optimize formulations.[1][5]

 

Conclusion

Emerging evidence supports nutraceuticals as safe, effective complementary and integrative therapeutic strategies for migraine management. Riboflavin, CoQ10, magnesium, omega-3 fatty acids, alpha-lipoic acid, vitamin D, B vitamins,  cocoa, and probiotics demonstrate varying levels of evidence for migraine prophylaxis and treatment. These agents modulate oxidative stress, inflammation, mitochondrial function, and gut microbiome composition—all implicated in migraine pathogenesis.[1][2][3]

However, one should recognize evidence limitations and understand the variable quality of unregulated supplements, and emphasize that nutraceuticals complement rather than replace evidence-based medical management. Personalized approaches considering individual nutrient status, genetic factors, and migraine characteristics will optimize therapeutic outcomes.

References

  1. Review on Headache Related to Dietary Supplements. Ariyanfar S, Razeghi Jahromi S, Togha M, Ghorbani Z. Current Pain and Headache Reports. 2022;26(3):193-218. doi:10.1007/s11916-022-01019-9.
  2. Effects of Selected Dietary Supplements on Migraine Prophylaxis: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Talandashti MK, Shahinfar H, Delgarm P, Jazayeri S. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2025;46(2):651-670. doi:10.1007/s10072-024-07794-0.
  3. Linking Migraine to Gut Dysbiosis and Chronic Non-Communicable Diseases. Di Lauro M, Guerriero C, Cornali K, et al. Nutrients. 2023;15(20):4327. doi:10.3390/nu15204327.
  4. The Role of Gut Microbiota in Migraine: Effects of Probiotics, Prebiotics, and Their Combinations. Sivri D, Yıldıran H. The European Journal of Neuroscience. 2025;62(11):e70316. doi:10.1111/ejn.70316.
  5. The Brain, the Eating Plate, and the Gut Microbiome: Partners in Migraine Pathogenesis. Gazerani P, Papetti L, Dalkara T, et al. Nutrients. 2024;16(14):2222. doi:10.3390/nu16142222.
  6. Nutraceuticals and Headache 2024: Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur. Tepper SJ, Tepper K. Current Pain and Headache Reports. 2025;29(1):33. doi:10.1007/s11916-025-01358-3.
  7. Dietary Alteration of N-3 and N-6 Fatty Acids for Headache Reduction in Adults With Migraine: Randomized Controlled Trial. Ramsden CE, Zamora D, Faurot KR, et al. BMJ (Clinical Research Ed.). 2021;374:n1448. doi:10.1136/bmj.n1448.
  8. A 12-Week Randomized Double-Blind Clinical Trial of Eicosapentaenoic Acid Intervention in Episodic Migraine. Wang HF, Liu WC, Zailani H, et al. Brain, Behavior, and Immunity. 2024;118:459-467. doi:10.1016/j.bbi.2024.03.019.
  9. Food in Migraine Management: Dietary Interventions in the Pathophysiology and Prevention of Headaches-a Narrative Review. Poboży T, Janowski K, Michalak K, et al. Nutrients. 2025;17(21):3471. doi:10.3390/nu17213471.
  10. Effect of Vitamin D and/or Marine N-3 Fatty Acid Supplementation on Changes in Migraine Frequency and Severity. Rist PM, Buring JE, Cook NR, Manson JE, Kurth T. The American Journal of Medicine. 2021;134(6):756-762.e5. doi:10.1016/j.amjmed.2020.11.023.
  11. Altered Gut Microbiota in Individuals With Episodic and Chronic Migraine. Yong D, Lee H, Min HG, et al. Scientific Reports. 2023;13(1):626. doi:10.1038/s41598-023-27586-4.

 

Part II: Pathophysiological Foundations

Migraine Pathophysiology and Nutraceutical Targets

Migraine pathogenesis involves complex interactions between genetic predisposition and environmental triggers, manifesting through several key mechanisms that nutraceuticals can modulate:[1][4][5]

Mitochondrial Dysfunction and Energy Deficit

Phosphorus-31 nuclear magnetic resonance spectroscopy studies demonstrate brain energy deficits in migraineurs, suggesting impaired mitochondrial oxidative phosphorylation as an upstream pathogenic mechanism.[2][6] This energy deficit may lower the threshold for cortical spreading depression and trigeminovascular activation.

Nutraceuticals supporting mitochondrial function—including riboflavin, CoQ10, alpha-lipoic acid, and carnitine—address this fundamental metabolic abnormality. [2][3][6]

Oxidative Stress and Reactive Oxygen Species

Elevated ROS levels in migraine patients exceed cellular antioxidant capacity, causing DNA damage, lipid peroxidation, and activation of pronociceptive TRPA1 receptors in meningeal tissues.[1][7] Polyphenol-enriched nutraceuticals (grape seed extract, curcumin, cocoa) function as molecular scavengers, reducing oxidative damage and associated neuroinflammation.[1][8]

Neuroinflammation and Immune Dysregulation

Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and inflammatory mediators (prostaglandins, leukotrienes) contribute to peripheral and central sensitization.[1][9][10] Phytosterols (β-sitosterol in cocoa), omega-3 fatty acids, and curcumin suppress inflammatory signaling through glucocorticoid receptor activation, NF-κB inhibition, and modulation of cyclooxygenase and lipoxygenase pathways.[1][11][8][9]

Neurotransmitter Imbalance:

Dysregulation of serotonin, GABA, glutamate, and CGRP contributes to migraine pathogenesis.[1][5] Nutraceuticals influence neurotransmitter systems through multiple mechanisms: grape seed extract upregulates GAD 65/67 enzymes and GABAB receptors; cocoa modulates calcium channels affecting CGRP secretion; and gut microbiota-derived metabolites (SCFAs, GABA, serotonin) exert systemic neuromodulatory effects. [1][12]

Gut-Brain Axis Disruption

Emerging evidence implicates gut dysbiosis in migraine pathogenesis through altered production of neuroactive metabolites, increased intestinal permeability, systemic inflammation, and disrupted vagal signaling.[4][5][13][14] Nutraceuticals with prebiotic properties (cocoa, grape seed extract) and probiotics maintain commensal bacteria that produce anti-inflammatory SCFAs, particularly butyrate, propionate, and acetate.[1][5][15]

Mechanisms of Nutraceutical Action

Polyphenols:

These secondary plant metabolites exert pleiotropic effects including ROS scavenging, metal chelation, enzyme modulation (COX, LOX, iNOS inhibition), and gene expression regulation.[1][8] Grape seed proanthocyanidins, curcuminoids, and cocoa flavanols demonstrate particular relevance to migraine through their effects on vascular function, neuronal excitability, and inflammatory cascades.[1][8][16]

Phytosterols:

Plant sterols like β-sitosterol activate glucocorticoid receptors, inducing MKP-1 expression that inhibits pro-inflammatory MAP kinase signaling. [1][17] This mechanism parallels corticosteroid action but with superior safety profiles.

Vitamins and Cofactors

B vitamins (riboflavin, pyridoxine, folate, cobalamin) serve as essential cofactors in mitochondrial electron transport, one-carbon metabolism, and neurotransmitter synthesis.[2][3][6] Vitamin D functions as a neurosteroid with anti-inflammatory, antioxidant, and neuromodulatory properties.[18][19][20]

Minerals

Magnesium regulates NMDA receptors, calcium channels, neurotransmitter release, and mitochondrial function while preventing platelet aggregation and cortical spreading depression.[2][3][7] Deficiency is prevalent in migraineurs and correlates with attack frequency.[21][22]

Omega-3 Fatty Acids

EPA and DHA reduce neuroinflammation through multiple pathways: competitive inhibition of arachidonic acid metabolism, production of specialized pro-resolving mediators (resolvins, protectins), suppression of NF-κB activation, and modulation of membrane fluidity affecting ion channel function.[11][23][24][9]

References

1. Risk of Dementia Following Gabapentin Prescription in Chronic Low Back Pain Patients. Eghrari NB, Yazji IH, Yavari B, Van Acker GM, Kim CH. Regional Anesthesia and Pain Medicine. 2025;:rapm-2025-106577. doi:10.1136/rapm-2025-106577.

2. Review on Headache Related to Dietary Supplements. Ariyanfar S, Razeghi Jahromi S, Togha M, Ghorbani Z. Current Pain and Headache Reports. 2022;26(3):193-218. doi:10.1007/s11916-022-01019-9.

3. Effects of Selected Dietary Supplements on Migraine Prophylaxis: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Talandashti MK, Shahinfar H, Delgarm P, Jazayeri S. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2025;46(2):651-670. doi:10.1007/s10072-024-07794-0.

4. Linking Migraine to Gut Dysbiosis and Chronic Non-Communicable Diseases. Di Lauro M, Guerriero C, Cornali K, et al. Nutrients. 2023;15(20):4327. doi:10.3390/nu15204327.

5. The Role of Gut Microbiota in Migraine: Effects of Probiotics, Prebiotics, and Their Combinations. Sivri D, Yıldıran H. The European Journal of Neuroscience. 2025;62(11):e70316. doi:10.1111/ejn.70316.

6. Nutrients to Improve Mitochondrial Function to Reduce Brain Energy Deficit and Oxidative Stress in Migraine. Fila M, Chojnacki C, Chojnacki J, Blasiak J. Nutrients. 2021;13(12):4433. doi:10.3390/nu13124433.

7. Nutraceuticals and Headache 2024: Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur. Tepper SJ, Tepper K. Current Pain and Headache Reports. 2025;29(1):33. doi:10.1007/s11916-025-01358-3.

8. The Impact of Curcumin on Migraine: A Comprehensive Review. Heidari H, Shojaei M, Askari G, et al. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023;164:114910. doi:10.1016/j.biopha.2023.114910.

9. The Synergistic Effects of Ω-3 Fatty Acids and Nano-Curcumin Supplementation on Tumor Necrosis Factor (TNF)-α Gene Expression and Serum Level in Migraine Patients. Abdolahi M, Tafakhori A, Togha M, et al. Immunogenetics. 2017;69(6):371-378. doi:10.1007/s00251-017-0992-8.

10. The Efficacy of Ginger for the Treatment of Migraine: A Meta-Analysis of Randomized Controlled Studies. Chen L, Cai Z. The American Journal of Emergency Medicine. 2021;46:567-571. doi:10.1016/j.ajem.2020.11.030.

11. Dietary Alteration of N-3 and N-6 Fatty Acids for Headache Reduction in Adults With Migraine: Randomized Controlled Trial. Ramsden CE, Zamora D, Faurot KR, et al. BMJ (Clinical Research Ed.). 2021;374:n1448. doi:10.1136/bmj.n1448.

12. The Effect of Three Different Ketogenic Diet Protocols on Migraine and Fatigue in Chronic and High-Frequency Episodic Migraine: A Pilot Study. Tereshko Y , Dal Bello S, Di Lorenzo C, et al. Nutrients. 2023;15(20):4334. doi:10.3390/nu15204334.

13. The Brain, the Eating Plate, and the Gut Microbiome: Partners in Migraine Pathogenesis. Gazerani P, Papetti L, Dalkara T, et al. Nutrients. 2024;16(14):2222. doi:10.3390/nu16142222.

14. Efficacy and Safety of 6.25 Mg t.i.d. Feverfew CO2-extract (MIG-99) in Migraine Prevention–a Randomized, Double-Blind, Multicentre, Placebo-Controlled Study. Diener HC, Pfaffenrath V , Schnitker J, Friede M, Henneicke-von Zepelin HH. Cephalalgia : An International Journal of Headache. 2005;25(11):1031-41. doi:10.1111/j.1468-2982.2005.00950.x.

15. Poor Adherence to the Mediterranean Diet and Sleep Disturbances Are Associated With Migraine Chronification and Disability Among an Adult Population in the Lazio Region, Italy. Bovenzi R, Noce A, Conti M, et al. Nutrients. 2024;16(13):2169. doi:10.3390/nu16132169.

16. Turmeric and Curcumin: From Traditional to Modern Medicine. Akaberi M, Sahebkar A, Emami SA. Advances in Experimental Medicine and Biology. 2021;1291:15-39. doi:10.1007/978-3-030-56153-6_2.

17. Migraine Prevention in Children and Adolescents: Results of an Open Study With a Special Butterbur Root Extract. Pothmann R, Danesch U. Headache. 2005;45(3):196-203. doi:10.1111/j.1526-4610.2005.05044.x.

18. Vitamin D in Migraine Headache: A Comprehensive Review on Literature. Ghorbani Z, Togha M, Rafiee P, et al. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2019;40(12):2459-2477. doi:10.1007/s10072-019-04021-z.

19. The Role of Vitamin D in Primary Headache-From Potential Mechanism to Treatment. Nowaczewska M, Wiciński M, Osiński S, Kaźmierczak H. Nutrients. 2020;12(1):E243. doi:10.3390/nu12010243.

20. Vitamin D Supplementation for the Treatment of Migraine: A Meta- Analysis of Randomized Controlled Studies. Hu C, Fan Y , Wu S, Zou Y , Qu X. The American Journal of Emergency Medicine. 2021;50:784-788. doi:10.1016/j.ajem.2021.07.062.

21. Dietary Patterns and Migraine: Insights and Impact. Tu YH, Chang CM, Yang CC, et al. Nutrients. 2025;17(4):669. doi:10.3390/nu17040669.

22. The Role of Diet and Nutrition in Migraine Triggers and Treatment: ASystematic Literature Review. Hindiyeh NA, Zhang N, Farrar M, et al. Headache. 2020;60(7):1300-1316. doi:10.1111/head.13836.

23. A 12-Week Randomized Double-Blind Clinical Trial of Eicosapentaenoic Acid Intervention in Episodic Migraine. Wang HF, Liu WC, Zailani H, et al. Brain, Behavior, and Immunity. 2024;118:459-467. doi:10.1016/j.bbi.2024.03.019.

24. Food in Migraine Management: Dietary Interventions in the Pathophysiology and Prevention of Headaches-a Narrative Review. Poboży T, Janowski K, Michalak K, et al. Nutrients. 2025;17(21):3471. doi:10.3390/nu17213471.

25. Cutaneous Application of Menthol 10% Solution as an Abortive Treatment of Migraine Without Aura: A Randomised, Double-Blind, Placebo- Controlled, Crossed-Over Study. Borhani Haghighi A, Motazedian S, Rezaii R, et al. International Journal of Clinical Practice. 2010;64(4):451-6. doi:10.1111/j.1742-1241.2009.02215.x.

26. Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations. Kazemi A, Iraji A, Esmaealzadeh N, Salehi M, Hashempur MH. Critical Reviews in Food Science and Nutrition. 2025;65(8):1553- 1578. doi:10.1080/10408398.2023.2296991.

27. The Synergistic Effects of Nano-Curcumin and Coenzyme Q10 Supplementation in Migraine Prophylaxis: A Randomized, Placebo- Controlled, Double-Blind Trial. Parohan M, Sarraf P, Javanbakht MH, et al. Nutritional Neuroscience. 2021;24(4):317-326. doi:10.1080/1028415X.2019.1627770.

Other Supplements Potentially Effective for Headache Prevention

(Limited Evidence)

Acetyl-L-Carnitine & Alpha Lipoic Acid (aka Thioctic Acid)

There  is evidence to suggest they are helpful in reducing the frequency and severity of migraines and the pain associated with fibromyalgia.

See Acetyl-L-Carnitine

   Dose: 500-1000mg 2x/day

See Alpha Lipoic Acid

   Dose: 600mg/day, take on an empty stomach

 Avocado-Soy Unsaponifialbles (ASU)

This may improve the pain and stiffness associated with arthritis, especially in the hips and knees. It has an excellent safety record.

  • Dose: 150mg twice/day

Bromelain

Derived from pineapples, Bromelain may be effective for acute inflammation and for acute flare-ups of chronic inflammation as found in arthritis and LBP.

  • Dose: 250mg – 300mg twice/day
  • Precautions: Preparations that are enteric coated allow for best absorption.
  • Contraindications: Should not be used with warfarin (coumadin)

Butterbur – NOT RECOMMENDED

While butterbur was previously recommended for migraines, it has been found to contain substances that can damage the liver and may cause cancer.

Do not use butterbur products

Butterbur (Petasites Hybridus) may be very helpful in reducing the severity and frequency of migraine headaches and is safe for children. It also can be helpful with seasonal allergies. Clinical benefits may not become apparent for 2-3 months. It is marketed under the brand name Petadolex.
Dose: 75mg 2x/day x 4 weeks then 50mg 2x/day (available as “Petadolex”)
Precautions: Do not ingest the plant itself, it contains a toxic alkaloid that must be removed prior to ingestion. Be certain that the product label confirms this. Some people may experience stomach upset, including gas, when they take butterbur. It is not recommended for young children or women who are pregnant or breast-feeding. Side effects may include belching.

Devil’s Claw

Derived from an African plant and used in Europe for decades, this may improves low back pain and the pain associated with arthritis. It has an excellent safety record.

  • Dose: 150mg/day

 

Feverfew

Though generally not thought to be as effective as butterbur in managing migraine headaches it nevertheless can be helpful.

  • Dose: 100-125mg/day (CO2 extract)
  • Precautions: To be most effective, the leaf must be freshly picked, freezed dried or a CO2 extract. People who take feverfew for a long time and suddenly stop taking it may have headaches, nervousness, insomnia, stiff muscles, and joint pain.

 

Magnesium (Epsom Salt)

See: Magnesium

Magnesium may be very effective in preventing migrain headaches. Magnesium in the form of epsom salt baths is absorbed through the skin and may reduce the frequency and severity of headaches, sometimes dramatically. It also may help protect against the development of diabetes. It is estimated that 60-80% of people older than 50 are magnesium deficient.

  • Dose: 350-700mg/day or epsom baths 3-4x/week
  • Precautions: Caution with kidney disease. Diarrhea is a common side effect.

Melatonin

See:  Melatonin

 

Omega 3

See: Omega 3

This supplement offers many benefits including improving the pain associated with fibromyalgia, arthritis and the pain associated with menstruation. It also reduces the severity and frequency of migraine headaches. Some studies argue for the need to obtain Omega 3 from fish oil or natural sources (fish, krill) to be effective.

  • Dose: 2 – 3 gms/day of Omega3 (total of EPA + DPA).

Rhodiola Rosea

See: Rhodiola Rosea

This plant has been used in folk medicine for hundreds of years to improve mental clarity and fatigue. Studies show that it may be effective for anxiety, depression and insomnia. It is commonly used as an Adaptogen and has weak evidence for headache prevention

  • Dose: 340mg – 680mg/day
  • Precautions: Purchase only preparations that are labelled “Standardized to 3% Rosavin) to assure proper quality and dosing.

See: Rhodiola Rosea

  

Salicin

Salicin is chemically related to aspirin and offers the same pain benefits but does not affect platelets so it offers no protection against heart attacks or strokes. It is derived from willow bark but can be found in many other plants including meadowsweet, willow bark, cottonwood, poplar, aspen and wintergreen. This is actually an abortive for headaches, not a preventative.

  • Dose: 240mg /day
  • Contraindications: Should not be used by those allergic to aspirin.

 

SAMe (S-adenosylmethiomine)

See: SAMe

This is a precursor to many of the neurotransmitters that play a role in pain and depression. Having been in popular use in Europe since 1975, SAMe may offer relief for the pain of arthritis with effectiveness equal to ibuprofen and other non steroidal anti-inflammatories (NSAIDs). It is also useful for treating depression with effectiveness equal to many prescription antidepressants. It may take one or more weeks of use for the benefits to be fully appreciated. SAMe appears to be free of any interactions with other medications and has few if any side effects.

  •  Dose: Up to 1200mg – 1400mg/day. Start by taking 200mg twice a day and build the dose up slowly, increasing the dose every week or so until a maximum benefit is perceived.
  • Precautions: SAMe should be avoided in those with bipolar disorder as it may trigger manic behavior.

Commercial Products

Some commercial products offer combinations of various compounds recommended for migraine, headache prevention. The question arises as to whether or not the doses of the individual compounds in the combination product are high enough to provide the benefits promoted. No studies have been done for most of these products to determine if they really work.

 

References

 Headaches – Medication-Overuse Headaches

  1. Update on Medication-Overuse Headache and Its Treatment – 2015
  2. Medication-overuse headache – a review – 2014
  3. EFNS_guideline_2011_treatment_of_medication_overuse_headache
  4. Practical management of medication-overuse headache – 2006
  5. Medication overuse headache is a manifestation of opioid induced hyperalgesia – a neuroimmune hypothesis and novel approach to treatment – 2013
  6. Medication-overuse headache and opioid-induced hyperalgesia – A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment – 2012
  7. Codeine, Heightened Pain Sensitivity and Medication Overuse Headache – A Neuroimmune Hypothesis and Novel Treatment Strategy. – 2015
  8. A Critical Evaluation on MOH Current Treatments. 2017 – PubMed – NCBI
  9. The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine – 2018
  10. Treatment of withdrawal headache in patients with medication overuse headache – a pilot study – 2017
  11. Health and quality of life in patients with medication overuse headache syndrome after standardized inpatient rehabilitation – 2017
  12. OnabotulinumtoxinA in the treatment of patients with chronic migraine – clinical evidence and experience – 2017
  13. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headach – 2015 – PubMed – NCBI
  14. Treatment of medication-overuse headache – A systematic review. – PubMed – NCBI
  15. Effect of selective serotonin reuptake inhibitor treatment on the prognosis of patients with medication overuse headache – 2018
  16. Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH) – a prospective, randomized, open-label trial – 2013
  17. Detoxification for medication overuse headache is the primary task – 2011
  18. Detoxification for medication overuse headache is not necessary. 2012 – PubMed – NCBI
  19. Treatment of withdrawal headache in patients with medication overuse headache -a pilot study – 2017
  20. Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine – 2018

 

 Headaches – Medication-Overuse Headaches – Novel New Management

  1. Medication overuse headache is a manifestation of opioid induced hyperalgesia – a neuroimmune hypothesis and novel approach to treatment – 2013
  2. Medication-overuse headache and opioid-induced hyperalgesia – A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment – 2012
  3. Codeine, Heightened Pain Sensitivity and Medication Overuse Headache – A Neuroimmune Hypothesis and Novel Treatment Strategy. – 2015
  4. The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine – 2018
  5. OnabotulinumtoxinA in the treatment of patients with chronic migraine – clinical evidence and experience – 2017
  6. Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine – 2018
  7. Botulinum Toxin Type A—A Modulator of Spinal Neuron–Glia Interactions under Neuropathic Pain Conditions – 2018

 

 CAM, Headaches – Overview

  1. Headaches – Diet & CAM Summary
  2. Dietary Supplements for Pain and Headache _Supplemental Article

 

CAM, Headaches – Butterbur

  1. Prophylaxis for Migraine- Herbal Remedies

 

CAM, Headaches – Vitamin D

  1. Vit D levels in pain and headache patients

Emphasis on Education

 

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

 

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

 

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

 

For more information, please contact Accurate Clinic.

 

Supplements recommended by Dr. Ehlenberger may be purchased commercially online or at Accurate Clinic.

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.

Accurate Supplement Prices

 

 

.